Company / Cost of Revenue
Cardinal Health Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$214.4B
FY2025
5-year range
$138.7B / $219.4B
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#4 of 113
Health Care
What the data says
Among 113 Health Care companies, Cardinal Health is in the bottom 4% for cost of revenue. Cost of Revenue has fluctuated over the past 10 years, ranging from $85.9B in FY2016 to $219.4B in FY2024.
Based on SEC 10-K filings.
$214.4B in FY2025 with a 5-year CAGR of +10.6%. Top quartile in the Health Care sector.
Increased from $198.1B to $214.4B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +7.0%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 113This company $214.4B Sector average $11.3B
▼
+1798.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +10.6%, indicating consistent growth.
- In FY2025, cost of revenue decreased 2.3% year-over-year.
- Ranks #4 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.27 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $214.4B | -2.3% |
| FY2024 | $219.4B | +10.8% |
| FY2023 | $198.1B | +13.3% |
| FY2022 | $174.8B | +26.1% |
| FY2021 | $138.7B | +7.0% |
| FY2020 | $129.6B | +5.0% |
| FY2019 | $123.4B | -4.8% |
| FY2018 | $129.6B | +33.9% |
| FY2017 | $96.8B | +12.7% |
| FY2016 | $85.9B | -11.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026